Dr. Tewodros Melesse,
Director-General International Planned Parenthood Federation,
“We welcome private
sector support to be
more innovative and
scale up services to
Working together for sustainable improvements
The challenge of answering pressing healthcare issues worldwide is a mammoth task that no aid organization, government, company or research institute can manage alone. However, as part of a network of strong partners it is possible to make a real difference.
Bayer HealthCare therefore initiates and supports many cooperation projects that are committed to improving healthcare – be it in family planning, the fight against neglected and infectious diseases, training medical personnel, sex-education campaigns, or programs to give people with low incomes access to the drugs they need. In addition to donating medicines or money to overcome acute emergencies, our engagement concentrates mainly on sustainable concepts for long-term improvements in healthcare.
Our partners include governmental and non-governmental organizations with longstanding experience in their respective fields, global networks and local contacts.
Global engagement with strong partners
For over 40 years, Bayer HealthCare, in collaboration with partners, has been committed to giving women in developing countries the chance of self-determined family planning using quality hormonal contraceptives.
Another area in which we cooperate closely with various partners is in the fight against neglected tropical diseases (NTDs), which threaten 1.4 billion people worldwide; the poorest of the poor in developing and transition countries are particularly at risk.
As in the case of family-planning programs, the fight to defeat these diseases and improve people's living conditions can only be won as part of a concerted, major international effort. In 2012, thirteen pharmaceutical companies, the governments of the United States, the UK, and the United Arab Emirates, the Bill & Melinda Gates Foundation, the World Bank and other global health organizations launched the biggest campaign to date in the fight against the neglected tropical diseases. The aim: to contain or eradicate ten neglected tropical diseases in collaboration with the countries affected.
The strength of the initiative is that renowned partners with global influence are using their respective expertise and organizational skills in a concerted action to achieve the agreed goals. For example, partners are extending programs to provide drugs, thus covering requirements up to 2020. They are also providing research knowledge, molecules and funds to develop new drugs and a system for distributing drugs faster. In the London Declaration on Neglected Tropical Diseases, the participants furthermore undertake to cooperate more closely and to document progress.
In the course of the initiative, Bayer is particularly active in projects fighting Chagas disease and African sleeping sickness. We are also making molecules available from our library of compounds for the development of new therapies.